Home And Locally Observed - Tracking (HALO-Trak)

Summary

The goal of this observational study is to collect biometric, HRQoL, immune response and genomic data continuously and intermittently during and after chemo or immunotherapy for the generation of a complex dataset using a platform which can aggregate different types of data collected over a time period and, to test the potential for analysis within and across data sets with linkage to clinical outcomes. The framework will have capabilities to integrate data from electronic medical records (EMRs) such as Epic, as well as digital streams including sensor, genomic, imaging and pathology. Such a platform can realise the potential for machine learning (ML) methodologies to address important cancer outcomes.

Eligibility

Inclusion Criteria:

* ● A diagnosis of a metastatic or haematological cancer undergoing systemic therapy

  * Undergoing at least 1 planned cycle of chemotherapy or immunotherapy, according to standard of care practices.
  * Ability to understand and the willingness to sign a written informed consent.
  * Able to ambulate without assistance or walking aid.
  * Have an Android or iOS phone and willing to download the Ethera app

Exclusion Criteria:

* ● Physical disabilities that preclude daily walking

  * Inability to provide informed consent.
  * Unable to use and operate the Ethera Health Monitoring Smartphone App. (Apple or Android)
  * Medical or psychiatric condition which in the investigator's opinion would affect the successful completion of the study.

Conditions2

Browse More Trials